
|Articles|February 19, 2008
CVS to pay $40 million to settle Caremark investigation
CVS must pay more than $40 million for Caremark's business practices.
Advertisement
When
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
Experts Urge Pneumococcal Vaccination for Older Patients With Chronic Respiratory Disease
5




























